Who's fault will it be next?
Cen Biotech Inc 2022 Current Report 8-K
sec.report
Companies
Documents
Forms
Alerts
Item 4.01 Changes in Registrant's Certifying Accountant. Dismissal of Independent Registered Accounting Firm On May 2, 2022, the Board of Directors (the "Board") of CEN Biotech, Inc., an Ontario, Canada corporation (the "Company") approved the dismissal of Mazars USA LLP ("Mazars"), as its independent registered accounting firm, effective immediately. Mazars was engaged by the Company on January 16, 2018. No audit report of Mazars for the years ended December 31, 2021 or December 31, 2020, contained an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, with the exception of providing an explanatory paragraph stating there was substantial doubt about the Company's ability to continue as a going concern. During the Company's two most recent fiscal years and through May 2, 2022, (i) there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and Mazars on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which, if not resolved to the satisfaction of Mazars, would have caused Mazars to make reference to the subject matter of such disagreement in connection with its reports on the financial statements for such periods and (ii) there were no "reportable events" (as defined in Item 304(a)(1)(v) of Regulation S-K). The Company provided Mazars with a copy of the disclosure contained herein, prior to its filing with the Securities and Exchange Commission (the "Commission") and requested that Mazars furnish the Company with a letter addressed to the Commission stating whether or not it agreed with the statements herein and, if not, stating the respects in which it does
Use a basic web and google earth search or call your broker
